Shenzhen Hepalink Pharmaceutical Co Ltd Free Cash Flow Generation Index
Shenzhen Hepalink Pharmaceutical Co Ltd free cash flow generation index. Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Free Cash Flow Generation Index of 0.97x as of September 2025. Free cash flow of CN¥385.83 Million represents 1% of operating cash flow (CN¥399.43 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Shenzhen Hepalink Pharmaceutical Co Ltd (2006–2025)
Free cash flow generation index of Shenzhen Hepalink Pharmaceutical Co Ltd from 2006 to 2025. Historical FCF Generation Index trend for Shenzhen Hepalink Pharmaceutical Co Ltd across 16 annual periods. See Shenzhen Hepalink Pharmaceutical Co Ltd (002399) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Shenzhen Hepalink Pharmaceutical Co Ltd Free Cash Flow Generation Index by Year (2006–2025)
Shenzhen Hepalink Pharmaceutical Co Ltd free cash flow generation index by year from 2006 to 2025. Year-by-year Free Cash Flow Generation Index for Shenzhen Hepalink Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Shenzhen Hepalink Pharmaceutical Co Ltd (002399) cash flow conversion.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.93x | CN¥1.59 Billion | CN¥1.71 Billion | CN¥121.10 Million | ▲ +2.4% |
| 2024 | 0.91x | CN¥1.99 Billion | CN¥2.19 Billion | CN¥202.77 Million | ▲ +874.5% |
| 2023 | -0.12x | CN¥-46.66 Million | CN¥398.22 Million | CN¥444.88 Million | ▲ +97.5% |
| 2020 | -4.70x | CN¥-175.21 Million | CN¥37.28 Million | CN¥212.49 Million | ▼ -2462.3% |
| 2018 | 0.20x | CN¥132.86 Million | CN¥667.87 Million | CN¥535.01 Million | ▲ +611.3% |
| 2016 | -0.04x | CN¥-13.46 Million | CN¥346.07 Million | CN¥359.54 Million | ▼ -104.8% |
| 2015 | 0.81x | CN¥724.86 Million | CN¥893.71 Million | CN¥168.85 Million | ▼ -0.6% |
| 2014 | 0.82x | CN¥745.18 Million | CN¥912.80 Million | CN¥167.62 Million | ▲ +170.6% |
| 2013 | 0.30x | CN¥126.99 Million | CN¥420.97 Million | CN¥293.98 Million | ▼ -39.5% |
| 2012 | 0.50x | CN¥236.34 Million | CN¥473.89 Million | CN¥237.55 Million | ▼ -44.9% |
| 2011 | 0.90x | CN¥1.27 Billion | CN¥1.41 Billion | CN¥134.16 Million | ▲ +0.6% |
| 2010 | 0.90x | CN¥318.93 Million | CN¥354.86 Million | CN¥35.93 Million | ▲ +6.3% |
| 2009 | 0.85x | CN¥300.89 Million | CN¥355.81 Million | CN¥54.91 Million | ▲ +15.8% |
| 2008 | 0.73x | CN¥29.32 Million | CN¥40.13 Million | CN¥10.81 Million | ▲ +433.6% |
| 2007 | 0.14x | CN¥1.90 Million | CN¥13.85 Million | CN¥11.95 Million | ▼ -83.9% |
| 2006 | 0.85x | CN¥60.95 Million | CN¥71.66 Million | CN¥10.71 Million | — |